WHO releases its first-ever Guidance to tackle Antibiotic pollution from manufacturing processes | Current Affairs | Vision IAS
News Today Logo

WHO releases its first-ever Guidance to tackle Antibiotic pollution from manufacturing processes

Posted 12 Sep 2024

2 min read

It addresses the antibiotic discharge from manufacturing which is recognised as a significant driver of the growing Antimicrobial Resistance (AMR) crisis.

AMR caused by pharmaceutical manufacturing

  • Wastewater generated from antibiotic manufacturing, containing antibiotic residue, pollutes the water bodies like rivers and also seeps into the land.
  • Currently, antibiotic pollution from manufacturing is largely unregulated and quality assurance criteria typically do not address environmental emissions.

About AMR

  • AMR occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines. (As per WHO)
  • It is a natural process that happens over time through genetic changes in pathogens. 
  • Its emergence and spread is accelerated by human activity, mainly the misuse and overuse of antimicrobials.
  • The creation of “superbugs” affects healthcare everywhere, but has especially poor outcomes in patients suffering from multiple diseases.

Concerns related to AMR

  • Human and animal health: WHO lists AMR among the top 10 threats for global health. 
    • In 2019, 1.27 million deaths were directly attributed to drug-resistant infections globally.
  • Environment: AMR has a potential to negatively impact biodiversity through pollution and rise of zoonotic diseases.
  • Food and nutrition security: AMR threatens agriculture and animal husbandry. 
  • Economic development and social equity: productivity losses, increased healthcare costs and rise in poverty.

Initiatives to tackle AMR

  • Adopting One Health Approach: Integrated approach aiming at sustainably balancing and optimising health of people, animals and ecosystems.
  • WHO Good Manufacturing Practices (GMP), 2020: Inclusion of environmental aspects of manufacturing linked to waste management etc.
  • National action plan on containment of Antimicrobial Resistance (NAP-AMR), 2017
  • Ban on 40 fixed dose combinations (FDCs) which were found inappropriate.
  • Ban on Colistin as growth promoter in poultry.
  • Development of antimicrobial vaccine, AV0328: Bharat Biotech in collaboration with a US firm.
  • Tags :
  • AMR
  • Pharmaceutical Sector
  • Antimicrobial Resistance
Watch News Today